| タイ | トルコ | オーストリア | |
| リンパ腫化学療法 | から $3,200 / 108,800฿ | から $3,000 / 102,000฿ | から $8,000 / 272,000฿ |
Bookimedはリンパ腫化学療法価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。到着時にクリニックでリンパ腫化学療法代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。リンパ腫化学療法で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。リンパ腫化学療法の旅路でお一人になることはありません。
Dr. Kodchanut Litleaungdej is a hematologist at Intrarat Hospital in Bangkok. She specializes in the treatment of leukemia, myeloma, and complex lymphomas. Dr. Litleaungdej co-authored a clinical risk prediction model for cancer-associated venous thromboembolism. She graduated with second-class honors from Naresuan University before completing a hematology fellowship at Thammasat University.
Lymphoma chemotherapy in Thailand is administered by specialized hematologists and medical oncologists. These doctors typically complete 13 years of rigorous medical training. This includes specialized fellowships in blood disorders and mandatory board certification from the Medical Council of Thailand within JCI-accredited facilities.
Bookimed Expert Insight: While local certification is mandatory, 1,300 doctors at top-tier Thai hospitals often hold dual certifications. Data shows these specialists frequently complete fellowships at prestigious institutions like the Mayo Clinic. This high concentration of Western-trained experts in Bangkok ensures global treatment standards for lymphoma.
Patient Consensus: Patients frequently highlight the benefit of lower nurse-to-patient ratios during chemotherapy sessions in Thailand. Many feel the 24/7 monitoring at JCI-accredited hospitals provides superior safety compared to their home countries.
Thailand provides international standard lymphoma protocols including R-CHOP, ABVD, and R-ICE, primarily following NCCN guidelines. Multi-disciplinary teams at JCI-accredited centers like Bumrungrad International Hospital offer these regimens along with targeted therapies like Polatuzumab vedotin and immunotherapies such as Pembrolizumab.
Bookimed Expert Insight: While Thailand matches Western standards for most regimens, some specific drugs like procarbazine are unavailable locally. This makes the eBEACOPP protocol difficult to replicate exactly. Patients requiring intensive Hodgkin treatments should confirm if hospitals can source suitable alternatives before traveling.
Patient Consensus: Many patients recommend verifying whether a clinic uses brand-name drugs or Thai FDA-approved biosimilars. Those treated at top-tier centers often highlight that R-mini-CHOP is a frequent, effective choice for older patients.
Chemotherapy schedules in Thailand often allow for sightseeing during recovery windows, typically 10 to 21 days after an infusion. Leading institutions like Bumrungrad International Hospital serve over 500,000 international patients annually, frequently coordinating treatment cycles with low-impact travel plans to manage fatigue and infection risks safely.
Bookimed Expert Insight: Thai oncologists often accommodate international patients by condensing 3-week CHOP regimens into slightly modified schedules. This flexibility allows patients to frequent Bangkok's quieter outskirts between sessions. Specialized hematologists like Kodchanut Litleaungdej MD at Intrarat Hospital focus specifically on managing cancer-associated risks during these active periods.
Patient Consensus: Patients suggest booking hotels with high-quality air conditioning to combat treatment-related exhaustion. Many recommend prioritizing short, private tours over group excursions to maintain energy and reduce exposure to crowds.
Thai JCI-accredited hospitals provide professional medical interpreters and dedicated international patient coordinators (IPCs) for chemotherapy. These specialists manage oncological terminology, visa logistics, and treatment schedules. Facilities like Bumrungrad International Hospital support over 190 nationalities with on-site multilingual support during drug infusions.
Bookimed Expert Insight: Data shows that choosing JCI-accredited centers in Bangkok significantly improves the patient experience. These top-tier clinics, like Bumrungrad, serve over 500,000 international patients annually. This massive volume ensures their staff are experts in diverse cultural needs. Many provide free on-site interpreters, effectively bundling high-level communication into standard care.
Patient Consensus: Patients value how dedicated coordinators handle all chemo logistics, including stressful visa renewals. This support allows families to focus entirely on recovery while avoiding language barriers in private wards.
Plan for a stay of 10 to 14 days per chemotherapy cycle in Thailand. This window covers essential pre-treatment blood work, the infusion process, and 3 to 5 days of clinical observation. Experts emphasize staying locally until your blood counts stabilize before flying home.
Bookimed Expert Insight: Data from major centers like Bumrungrad International Hospital show a trend toward outpatient-heavy cycles. However, international patients often underestimate post-chemo fatigue. We see better outcomes when patients book hotels within 1 kilometer of the clinic. This proximity allows for quick intravenous hydration if fever or dehydration occurs during the recovery week.
Patient Consensus: Many note that staying less than 7 days increases the risk of infection. They recommend budgeting a 20% time buffer for unexpected delays in blood count recovery.
Bangkok is the primary hub for lymphoma chemotherapy in Thailand, housing JCI-accredited facilities like Bumrungrad International Hospital and Samitivej Sukhumvit Hospital. These centers offer advanced protocols for Hodgkin and Non-Hodgkin subtypes, featuring specialized hematology-oncology departments and board-certified specialists with international training.
Bookimed Expert Insight: While many choose Bangkok for its 50% international patient base, local expertise resides at Siriraj Hospital. This academic powerhouse handles the most complex hematology cases in Southeast Asia. For international patients, private centers like Bumrungrad offer faster access to identical drug regimens used in the US.
Patient Consensus: Patients value the seamless coordination and significantly lower costs compared to Western facilities. Many recommend budgeting for multiple trips, as follow-up care or unexpected reactions may require extended stays beyond the initial treatment cycle.
Thailand achieves success rates for classical Hodgkin lymphoma as high as 94.6% using international protocols. Australia maintains slightly higher five-year survival rates across all lymphoma types at 79%. However, centres like Bumrungrad International Hospital offer comparable quality through JCI-accredited oncology departments and haematologists.
Bookimed Expert Insight: Thai oncology centres show a strong pattern of specialisation. Bumrungrad International Hospital serves patients from 190 countries, making up 50% of its intake. This high volume means doctors have handled virtually every lymphoma subtype. Medical teams often include 1,300+ doctors, providing multidisciplinary support that rivals major Australian hospitals.
Patient Consensus: Success depends on specific lymphoma subtypes. Patients suggest getting a full biopsy review and staging scans in Thailand. Most find that top clinics strictly follow international protocols. They also provide all medical records in English for easy handover to Australian GPs.
JCI-accredited facilities like Bumrungrad International Hospital and Intrarat Hospital are recommended for international lymphoma patients. These Bangkok centres provide specialised haematology-oncology teams. They offer diagnostics and coordinated chemotherapy protocols within integrated cancer centres. These facilities handle thousands of international cases every year.
Bookimed Expert Insight: Lymphoma treatment in Thailand is concentrated in Bangkok. Bumrungrad International Hospital alone manages over 500,000 international patients annually. This volume ensures that medical staff are familiar with international protocols. They also provide diagnostic support including pathology and imaging under one roof.
Patient Consensus: Patients recommend starting with major Bangkok hospitals that have international departments. They suggest requesting a specific haematology consultation rather than a general oncology triage. This ensures direct access to specialists and streamlines follow-up care within the medical system.
Patients undergoing lymphoma chemotherapy in Thailand generally stay for 7–14 days per treatment cycle. A full course often requires 6–8 cycles spaced 3–4 weeks apart. Many return to Australia between infusions if their oncologist confirms they are fit to fly.
Bookimed Expert Insight: High-volume Bangkok centres like Bumrungrad International Hospital use electronic health records to support shared care. This allows patients to start cycles in Thailand and coordinate follow-up blood tests with their Australian GP.
Patient Consensus: Stays depend on the chemotherapy regimen rather than the location. Most travellers suggest booking flexible flights to allow for recovery time if blood counts drop unexpectedly.